In Sickle Cell Project, Baylor Scientist Discovers Link to Fetal Hemoglobin Production with Ingenuity Variant Analysis from QIAGEN
27 Oct 2014

Just two decades ago, there were virtually no therapeutic treatments for patients with sickle cell anemia, a severe condition in which blood cells form rigid sickle shapes, damaging several organs in the body. Today, there’s not only a medication, but thanks to new research from Vivien Sheehan and data interpretation from QIAGEN’s Ingenuity Variant Analysis, scientists also have a promising new lead for another treatment option.

Show    per page
1 of 5     Page  1 2 3  ... Next 
Mount Sinai’s Novel Biomarker Predicts Treatment Outcome in Ovarian Cancer Using Ingenuity Pathway Analysis from QIAGEN ovarian cancer, biomarker discovery27 Oct 2014Read
QC Explained 1.0 - Quality Control for Point of Care Testing clinical qc2 Sep 2014Read
Characterization of a Point-of-Care Diagnostic for Ebola and Sudan Virus Detection ebola, viral hemorrhagic fever21 Aug 2014Read
Why is RVF Technology More Valuable? point of care solutions, vertical flow testing20 Aug 2014Read
Developments in the Determination of Nitrous Oxide using TD–GC air sampling, VOC monitoring23 Jul 2014Read
HemaSpot: Advanced Blood Sampling dried blood spots16 Jul 2014Read
Ultra High Sensitivity Analysis of Testosterone dried blood spots, Testosterone15 Jul 2014Read
Analysis of Circulating miRNA from Dried Blood Spots dried blood spots14 Jul 2014Read
Reducing the Hematocrit Effect for Dried Blood Spot Analysis dried blood spots14 Jul 2014Read
Performance Comparison of Filter Papers for Dried Blood Spot Analysis by LC-MS/MS dried blood spots14 Jul 2014Read

Popular tags in SelectScience